Monoclonal antibodies in multiple sclerosis treatment: current and future steps

Bibliographic Details
Main Authors: Claire L. Helliwell, Alasdair J. Coles
Format: Article
Language:English
Published: SAGE Publishing 2009-07-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756285609337827
_version_ 1828401621016510464
author Claire L. Helliwell
Alasdair J. Coles
author_facet Claire L. Helliwell
Alasdair J. Coles
author_sort Claire L. Helliwell
collection DOAJ
first_indexed 2024-12-10T09:48:28Z
format Article
id doaj.art-47f17880290a4fedba24c4f814952dad
institution Directory Open Access Journal
issn 1756-2856
language English
last_indexed 2024-12-10T09:48:28Z
publishDate 2009-07-01
publisher SAGE Publishing
record_format Article
series Therapeutic Advances in Neurological Disorders
spelling doaj.art-47f17880290a4fedba24c4f814952dad2022-12-22T01:53:43ZengSAGE PublishingTherapeutic Advances in Neurological Disorders1756-28562009-07-01210.1177/1756285609337827Monoclonal antibodies in multiple sclerosis treatment: current and future stepsClaire L. HelliwellAlasdair J. Coleshttps://doi.org/10.1177/1756285609337827
spellingShingle Claire L. Helliwell
Alasdair J. Coles
Monoclonal antibodies in multiple sclerosis treatment: current and future steps
Therapeutic Advances in Neurological Disorders
title Monoclonal antibodies in multiple sclerosis treatment: current and future steps
title_full Monoclonal antibodies in multiple sclerosis treatment: current and future steps
title_fullStr Monoclonal antibodies in multiple sclerosis treatment: current and future steps
title_full_unstemmed Monoclonal antibodies in multiple sclerosis treatment: current and future steps
title_short Monoclonal antibodies in multiple sclerosis treatment: current and future steps
title_sort monoclonal antibodies in multiple sclerosis treatment current and future steps
url https://doi.org/10.1177/1756285609337827
work_keys_str_mv AT clairelhelliwell monoclonalantibodiesinmultiplesclerosistreatmentcurrentandfuturesteps
AT alasdairjcoles monoclonalantibodiesinmultiplesclerosistreatmentcurrentandfuturesteps